Titanium(IV) oxide
Based on 1 Customer Validation
Titanium(IV) oxide is a photosensitizer and photocatalyst. Titanium(IV) oxide can be used as a pharmaceutical excipient such as a flow aid, coating agent, sunscreen, colorant, etc. Pharmaceutical excipients or pharmaceutical excipients refer to other chemical substances used in the pharmaceutical process other than the drug ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations that can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism and elimination (ADME) process of co-administered drugs. Titanium(IV) oxide can use light energy to generate electron-hole pairs to degrade pollutants. Photons excite electrons in TiO2 to generate active oxygen species (such as ·OH and ·O2-), thereby oxidizing and mineralizing pollutants such as organic compounds and heavy metals. TiO2 can be used in the research of environmental remediation fields such as water treatment, air purification and self-cleaning materials.
For research use only. We do not sell to patients.
- Assay : 98.46%
- CAS No.: 13463-67-7
- Formula: TiO2
- Molecular Weight:79.87
-
Storage:
4°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-W116336B
Zinc oxide, 99.99% metals basisBiochemical Assay Reagents -
HY-W116336D
Zinc oxide, <100 nm particle sizeNitrate Reductase Activator -
HY-Y0498
Aluminum oxideAdjuvant -
HY-Y0344D
Sodium chloride, for cell cultureBiochemical Assay Reagent -
HY-Y0649
Lithium chloride, 99.3%-TBiochemical Reagent -
HY-Y1878
Copper(Ⅱ) sulfateBiochemical Reagent -
HY-Y1878C
Copper sulfate anhydrous, 99%Bactericide -
HY-Y1267D
Magnesium sulfate, for cell cultureAnti-Inflammatory Agent -
HY-Y1267
Magnesium sulfateAnti-Inflammatory Agent -
HY-B1770
Sodium Iodide,99%Iodide Salt -
HY-Y0537
Potassium chloride, AR, 99.5%Potassium Supplement
Biological Activity
Description
In Vitro
Titanium(IV) oxide can effectively absorb light and generate electron-hole pairs for catalytic reactions, making it useful in a variety of environmental applications, including water and air purification, degradation of organic pollutants, and hydrogen production[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 13463-67-7
-
Appearance Solid
-
Molecular Weight 79.87
-
Formula TiO2
-
Color White to off-white
-
SMILES
O=[Ti]=O
-
Synonyms
Titanium dioxide
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Protocols
-
Protocol for Pharmacokinetic Study
Pharmacokinetic studies quantify how an organism handles a drug over time through absorption, distribution, metabolism, and excretion, and the core experimental readout is the concentration-time profile of parent drug and, when relevant, metabolites in biological matrices such as plasma, whole blood, urine, bile, or tissue. Pharmacokinetic analysis links dose, route, exposure, clearance, half-life, distribution, bioavailability, and systemic exposure to drug efficacy and toxicity hypotheses rather than measuring a signaling pathway directly. The literature links pharmacokinetics to drug-development phenotypes by showing that drug metabolism and pharmacokinetics influence compound progression, exposure-response interpretation, safety margins, dosing strategy, and failure risk during discovery and development. DMPK science contributes to compound optimization by integrating physicochemical properties, in vitro metabolism, transporter behavior, in vivo exposure, and pharmacodynamic contex
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Titanium(IV) oxide Related Classifications
HY-W051271 Related Classifications
Powered by Bioz
Keywords
- Titanium(IV) oxide
- 13463-67-7
- Titanium dioxide
- Environmental Pollutants
- Photosensitizer
- Reactive Oxygen Species (ROS)
- pharmaceutical excipient
- pharmaceutical auxiliarie
- pharmaceutical ingredients
- inactive ingredients
- stability
- solubility
- processability
- absorption
- distribution
- metabolism
- and elimination (ADME)
- Inhibitor
- inhibitor
- inhibit